GlassScriptPhysician profile
Wynona Blausey
NPI 1851938666
$5,119.15
in general payments reported to CMS, 2019-2025
36 companies · $540 in 2025
The $540 reported for 2025 was more than what 75% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,149 · 2022: $895 · 2023: $351 · 2024: $2,185 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,076.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $526.44 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $440.73 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $427.40 | 2021-2024 | Spravato |
| Astellas Pharma US INC | $320.51 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $246.83 | 2021-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.76 | 2021-2022 | |
| Abbvie INC. | $166.82 | 2024 | |
| Novartis Pharmaceuticals Corporation | $163.18 | 2021-2022 | |
| Lilly USA, LLC | $151.07 | 2024-2025 | Mounjaro, Kisunla |
| Sanofi-Aventis U.S. LLC | $138.41 | 2021-2024 | |
| Jazz Pharmaceuticals INC. | $125.00 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2024 | Rexulti |
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Eisai INC. | $124.94 | 2024 | |
| Vanda Pharmaceuticals INC. | $122.42 | 2025 | Ponvory |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $121.19 | 2024 | |
| Alkermes, INC. | $119.39 | 2024 | Vivitrol |
| Aimmune Therapeutics, INC. | $110.74 | 2025 | Zenpep |
| Inspire Medical Systems, INC. | $110.73 | 2024 | Inspire |
| Teva Pharmaceuticals USA, INC. | $106.58 | 2024 | Austedo Xr |
| Lundbeck LLC | $101.84 | 2024 | Vyepti |
| Bayer Healthcare Pharmaceuticals INC. | $100.00 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $98.74 | 2024 | Lumryz |
| Emd Serono, INC. | $88.63 | 2024 | |
| Axsome Therapeutics, INC. | $87.20 | 2024 | Sunosi |
| Merck Sharp & Dohme LLC | $85.58 | 2021-2022 | |
| Neurelis, INC. | $77.75 | 2024 | Valtoco |
| Amgen INC. | $76.61 | 2021-2022 | |
| Sk Life Science, INC. | $75.42 | 2025 | Xcopri |
| Amarin Pharma, INC. | $69.93 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $66.08 | 2024 | Inpefa |
| Pfizer INC. | $59.21 | 2021-2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $55.66 | 2024 | |
| Esperion Therapeutics, INC. | $49.40 | 2021-2022 | |
| Silk Road Medical, INC. | $37.99 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| E.R. Squibb & Sons, L.L.C. | $27.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wynona Blausey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.